Previous Close | 105.89 |
Open | 106.00 |
Bid | 107.68 x 800 |
Ask | 108.76 x 800 |
Day's Range | 105.78 - 108.31 |
52 Week Range | 102.89 - 135.45 |
Volume | |
Avg. Volume | 1,202,543 |
Market Cap | 18.927B |
Beta (5Y Monthly) | 1.18 |
PE Ratio (TTM) | 66.04 |
EPS (TTM) | 1.64 |
Earnings Date | Jan 27, 2025 - Jan 31, 2025 |
Forward Dividend & Yield | 5.20 (4.80%) |
Ex-Dividend Date | Sep 30, 2024 |
1y Target Est | 129.23 |
ARE announces that it has executed a 10-year lease with Vaxcyte, Inc., a clinical-stage biopharmaceutical company.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in AAA life science innovation cluster locations, today announced that it executed a 10-year lease with Vaxcyte, Inc., a clinical-stage biopharmaceutical company working to protect humankind from the consequences of bacterial diseases, for a total of 258,581 RSF at 825 Industrial Road on the Alexandria Center® for Life Science – San